SAN DIEGO, May 2, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) announced today that management will presentat the 2017 Bank of America Merrill Lynch Healthcare Conference on Tuesday, May 16th, at 4:20 PM PDT (7:20 PM EDT).
Investors, analysts, and
Orexigen Investor Contact:Jason Keyes, Chief Financial Officer+1-858- 875-8600 firstname.lastname@example.org
Orexigen Media Contact:Erika HackmannY&R+1-917-538-3375 email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/orexigen-therapeutics-to-provide-business-update-at-the-2017-bank-of-america-merrill-lynch-healthcare-conference-300450044.html
SOURCE Orexigen Therapeutics, Inc.
Subscribe to our Free Newsletters!
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...
Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient's ...
Sweet's syndrome or acute febrile neutrophilic dermatosis is a skin disorder with no specific ...View All